MYBPC3 gene variations in hypertrophic cardiomyopathy patients in India

Canadian Journal of Cardiology

Volumn 24, Issue 2, 2008, Pages 127-130

  Tanjore, Reena R ^a   Rangaraju, Advithi ^a   Kerkar, P G ^b   Calambur, Narsimhan ^c   Nallari, Pratibha ^a  

^a OSMANIA UNIVERSITY   (India)

^b KEM HOSPITAL   (India)

^c CARE HOSPITAL   (India)

Author keywords

Hypertrophic cardiomyopathy; MYBPC3; Nonsense mediated decay pathway; Novel mutation

Indexed keywords

MYOSIN BINDING PROTEIN C; MYOSIN BINDING PROTEIN C 3; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DNA ISOLATION; EXON; FEMALE; FRAMESHIFT MUTATION; GENE EXPRESSION; GENE FUNCTION; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INDIA; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 41349111495     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(08)70568-3     Document Type: Article

References (22)

1. Marian AJ, Mares A Jr, Kelly DP, et al. Sudden cardiac death in hypertrophic cardiomyopathy. Variability in phenotypic expression of beta-myosin heavy chain mutations. Eur Heart J 1995;16:368-76.
2. McKenna WJ, Behr ER. Hypertrophic cardiomyopathy: Management, risk stratification, and prevention of sudden death. Heart 2002;87:169-76.
3. Jääskeläinen P, Soranta M, Miettinen R, et al. The cardiac beta-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population. J Am Coll Cardiol 1998;32:1709-16.
4. Nishi H, Kimura A, Harada H, et al. Possible gene dose effect of a mutant cardiac beta-myosin heavy chain gene on the clinical expression of familial hypertrophic cardiomyopathy. Biochem Biophys Res Commun 1994; 200:549-56.
5. Gautel M, Zuffardi O, Freiburg A, Labeit S. Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: A modulator of cardiac contraction? EMBO J 1995;14:1952-60.
6. Schultheiss T, Lin ZX, Lu MH, et al. Differential distribution of subsets of myofibrillar proteins in cardiac nonstriated and striated myofibrils. J Cell Biol 1990;110:1159-72.
7. Schlender KK, Bean LJ. Phosphorylation of chicken cardiac C-protein by calcium/calmodulin-dependent protein kinase II. J Biol Chem 1991;266:2811-7.
8. Fougerousse F, Delezoide AL, Fiszman MY, Schwartz K, Beckmann JS, Carrier L. Cardiac myosin binding protein C gene is specifically expressed in heart during murine and human development. Circ Res 1998;82:130-3.
9. Lahiri DK, Numberger JI Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991;19:5444.
10. Bonne G, Carrier L, Bercovici J, et al. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet 1995;11:438-40.
11. Fung DC, Yu B, Littlejohn T, Trent RJ. An online locus-specific mutation database for familial hypertrophic cardiomyopathy. Hum Mutat 1999;14:326-32.
12. Richard P, Charron P, Carrier L, et al. Distribution of disease genes in 102 genotyped families with hypertrophic cardiomyopathy. Circulation 2001;104(Suppl)II-521.
13. Marian AJ, Roberts R. The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol 2001;33:655-70.
14. Keller DI, Carrier L, Schwartz K. Genetics of familial cardiomyopathies and arrhythmias. Swiss Med Wkly 2002;132:401-7.
15. Davies MJ. The cardiomyopathies: An overview. Heart 2000;83:469-74.
16. Watkins H, Rosenzweig A, Hwang DS, et al. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 1992;326:1108-14.
17. McKenna WJ, Coccolo F, Elliott PM. Genes and disease expression in hypertrophic cardiomyopathy. Lancet 1998;352:1162-3.
18. Arad M, Seidman JG, Seidman CE. Phenotypic diversity in hypertrophic cardiomyopathy. Hum Mol Genet 2002;11:2499-506.
19. Ortlepp JR, Vosberg HP, Reith S, et al. Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: A study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene. Heart 2002;87:270-5.
20. Charron P, Dubourg O, Desnos M, et al. Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene. Circulation 1998;97:2230-6.
21. Niimura H, Bachinski LL, Sangwatanaroj S, et al. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med 1998;338:1248-57.
22. Van Driest SL, Vasile VC, Ommen SR, et al. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004;44:1903-10.